Metabolic predictors of COVID-19 mortality and severity: a survival analysis.

Autor: Abdallah AM; College of Medicine, Qatar University (QU) Health, Qatar University, Doha, Qatar., Doudin A; Biomedical Research Center (BRC), Qatar University, Doha, Qatar., Sulaiman TO; Department of Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Jamil O; Department of Radiology, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Arif R; Emergency Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Sada FA; Neurosurgery Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Yassine HM; Biomedical Research Center (BRC), Qatar University, Doha, Qatar., Elrayess MA; College of Medicine, Qatar University (QU) Health, Qatar University, Doha, Qatar.; Biomedical Research Center (BRC), Qatar University, Doha, Qatar., Elzouki AN; College of Medicine, Qatar University (QU) Health, Qatar University, Doha, Qatar.; Department of Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Emara MM; College of Medicine, Qatar University (QU) Health, Qatar University, Doha, Qatar., Thillaiappan NB; College of Medicine, Qatar University (QU) Health, Qatar University, Doha, Qatar., Cyprian FS; College of Medicine, Qatar University (QU) Health, Qatar University, Doha, Qatar.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 May 10; Vol. 15, pp. 1353903. Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).

The retrospective study of the metabolic patterns of BCG-vaccination in type-2 diabetic individuals in COVID-19 infection.

Autor: Anwardeen NR; Biomedical Research Center (BRC), QU Health, Qatar University, Doha, Qatar., Cyprian FS; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar., Yassine HM; Biomedical Research Center (BRC), QU Health, Qatar University, Doha, Qatar.; College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Al-Thani AA; Biomedical Research Center (BRC), QU Health, Qatar University, Doha, Qatar.; College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Abdallah AM; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar., Emara MM; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar., Elrayess MA; Biomedical Research Center (BRC), QU Health, Qatar University, Doha, Qatar.; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Apr 05; Vol. 14, pp. 1146443. Date of Electronic Publication: 2023 Apr 05 (Print Publication: 2023).

Detection of Antinuclear Antibodies Targeting Intracellular Signal Transduction, Metabolism, Apoptotic Processes and Cell Death in Critical COVID-19 Patients.

Autor: Nasarallah GK; Biomedical Research Center, Qatar University, Doha, Qatar.; Department of Biomedical Sciences, College of Health Sciences-QU health, Qatar University, Doha, Qatar., Fakhroo AD; Research and Development Department, Barzan Holdings, Doha, Qatar., Khan T; Research Branch, Sidra Medicine, Doha, Qatar., Cyprian FS; Basic Medical Science Department, College of Medicine-QU Health, Qatar University, Doha, Qatar., Al Ali F; Research Branch, Sidra Medicine, Doha, Qatar., Ata MMA; Research Branch, Sidra Medicine, Doha, Qatar., Taleb S; Genomics and Precision Medicine, Hamad Bin Khalifa University, Doha, Qatar., Zedan HT; Biomedical Research Center, Qatar University, Doha, Qatar.; Department of Biomedical Sciences, College of Health Sciences-QU health, Qatar University, Doha, Qatar., Al-Sadeq DW; Biomedical Research Center, Qatar University, Doha, Qatar.; Basic Medical Science Department, College of Medicine-QU Health, Qatar University, Doha, Qatar., Amanullah FH; Biomedical Research Center, Qatar University, Doha, Qatar., Hssain AA; Hamad Medical Corporation, Doha, Qatar., Eid AH; Basic Medical Science Department, College of Medicine-QU Health, Qatar University, Doha, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar., Al-Khal A; Hamad Medical Corporation, Doha, Qatar., Al Thani AA; Department of Biomedical Sciences, College of Health Sciences-QU health, Qatar University, Doha, Qatar.; Research and Development Department, Barzan Holdings, Doha, Qatar., Marr N; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Yassine HM; Department of Biomedical Sciences, College of Health Sciences-QU health, Qatar University, Doha, Qatar.; Research and Development Department, Barzan Holdings, Doha, Qatar.

Publikováno v: Mediterranean journal of hematology and infectious diseases [Mediterr J Hematol Infect Dis] 2022 Nov 01; Vol. 14 (1), pp. e2022076. Date of Electronic Publication: 2022 Nov 01 (Print Publication: 2022).

Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease.

Autor: Bansal D; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Abdulmajeed J; Primary Health Care Corporation, Al Mina Street, Doha 26555, Qatar.; Department of Population Medicine, College of Medicine, QU Health, Qatar University, University Street, Doha 2713, Qatar., Al-Shamali MHMA; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Albayat SSA; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Himatt SM; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Cyprian FS; Immunology Division, Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Arab League Street, Doha 2713, Qatar., Chivese T; Department of Population Medicine, College of Medicine, QU Health, Qatar University, University Street, Doha 2713, Qatar., Mundodan JMA; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Khogali HS; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Baaboura R; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Kaleeckal AH; Hamad Medical Corporation, Doha 3050, Qatar., Kandy MC; Primary Health Care Corporation, Al Mina Street, Doha 26555, Qatar., Latif AN; Hamad Medical Corporation, Doha 3050, Qatar., Al-Kuwari MG; Primary Health Care Corporation, Al Mina Street, Doha 26555, Qatar., Al-Romaihi HE; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Al Khal A; Hamad Medical Corporation, Doha 3050, Qatar., Bertollini R; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Al-Thani MH; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Farag E; Ministry of Public Health, Ras Qertas Street, Doha 26555, Qatar., Doi SAR; Department of Population Medicine, College of Medicine, QU Health, Qatar University, University Street, Doha 2713, Qatar.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Jun 28; Vol. 10 (7). Date of Electronic Publication: 2022 Jun 28.

Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.

Autor: Cyprian FS; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Department of Basic Medical Sciences, College of Medicine, Member of QU Health, Qatar University, Doha, Qatar., Suleman M; Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan., Abdelhafez I; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar., Doudin A; Department of Math and Science, Community College of Qatar, Doha, Qatar., Masud Danjuma M; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Mir FA; Qatar Metabolic Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Parray A; The Neuroscience Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Yousaf Z; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Siddiqui MYA; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Abdelmajid A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Mulhim M; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Al-Shokri S; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Abukhattab M; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Shaheen R; Natural and Medical Sciences Research Centre, University of Nizwa, Nizwa, Oman., Elkord E; Natural and Medical Sciences Research Centre, University of Nizwa, Nizwa, Oman.; Biomedical Research Centre, School of Science, Engineering and Environment, University of Salford, Manchester, United Kingdom., Al-Khal AL; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Elzouki AN; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Girardi G; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Department of Basic Medical Sciences, College of Medicine, Member of QU Health, Qatar University, Doha, Qatar.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Dec 13; Vol. 12, pp. 707159. Date of Electronic Publication: 2021 Dec 13 (Print Publication: 2021).